Chinese PLA General Hospital
Beijing, China
Location status: Recruiting
NCT Number: NCT06340945
1. To evaluate the clinical outcomes of ultrasound-guided thermal ablationfor the treatment of benign thyroid nodules; 2. To develop and validate a artificial intelligence model to predict the outcomes of ultrasound-guided thermal ablation in the treatment of benign thyroid nodules
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Beijing, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
microwave ablation, radio frequency ablation, laser ablation
Time frame: through study completion, an average of 6 months
The volume reduction rate (VRR)was calculated by the equations: VRR=([initial volume-final volume] × 100)/initial volume
Time frame: through study completion, an average of 1 months
Regrowth was defined as ≥50% volume increase compared to the previously recorded smallest volume during the follow-up
Time frame: 1 week
complications after ablation
Time frame: through study completion, an average of 6 months
The cosmetic score was assessed by a physician (1, no palpable mass; 2, no cosmetic problem but palpable mass; 3, a cosmetic problem on swallowing only; and 4, a readily detected cosmetic problem)
Time frame: through study completion, an average of 6 months
The symptom score was self-measured by patients using a 10-cm visual analogue scale (grade 0-10)
Time frame: through study completion, an average of 6 months
vital volume was the incompletely treated vital volume which located peripherally
Time frame: through study completion, an average of 6 months
the overall volume of the nodules
Contact information is provided by the study sponsor or research team.
Chinese PLA General Hospital
Other
The Clinical Outcomes and Artificial Intelligence Prediction Model of Ultrasound-guided Thermal Ablation for the Treatment of Benign Thyroid Nodules:A Multicenter Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07226804
Endocrine Gland Neoplasms, Endocrine System Diseases
Houston, Texas, United States
View Trial DetailsNCT05189314
Endocrine Gland Neoplasms, Endocrine System Diseases
New York, United States
View Trial DetailsNCT07360587
Endocrine Gland Neoplasms, Endocrine System Diseases
Sherbrooke, Quebec, Canada
View Trial DetailsNCT07299474
Chronic Rhinosinusitis (CRS), Endocrine Gland Neoplasms
Los Angeles, California, United States
View Trial Details